Table 1

The assessments of the participants

Outcomes	Baseline	After a 3-month intervention	6 months after intervention	12 months after intervention
ICIQ-UI-SF	√	√	√	√
MOS	√	√
MVCP	√	√
POP-Q	√	√
Pelvic floor ultrasound	√	√
Three-dimensional body posture	√	√
Body weight	√	√	√	√
Abdominal circumference	√	√	√	√
I-QOL	√	√	√	√
POP-SS	√	√	√	√
OABSS	√	√	√	√
PISQ-12	√	√	√	√
EQ-5D-5L	√	√	√	√
HADS	√	√	√	√
BPMSES	√	√	√	√
PGI-I		√	√	√

BPMSES, Broome Pelvic Muscle Self-Efficacy Scale; EQ-5D-5L, European Quality of Life-5 Dimensions 5-Level questionnaire; HADS, Hospital Anxiety and Depression Scale; ICIQ-UI-SF, Incontinence Modular Questionnaire-Urinary Incontinence Short Form; I-QOL, Incontinence Quality of Life Instrument; MOS, Modified Oxford Scale; MVCP, maximum voluntary contraction pressure; OABSS, Overactive Bladder Symptom Score; PGI-I, Patient Global Impression of Improvement; PISQ-12, Short-form Prolapse Incontinence Sexual Questionnaire; POP-Q, Pelvic Organ Prolapse Quantification; POP-SS, Pelvic Organ Prolapse Symptom Score.